GDC-0927

DB14934InvestigationalSmall molecule

GDC-0927 is under investigation in clinical trial NCT02316509 (A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer).

Formula / weight: C₂₈H₂₈FNO₄ · 461.533 g/mol (avg)
Code names: GDC-0927

Resolves to

Compound

UNIIST9B0EMC0HCAS2100830-77-9

Structure

InChIKeyKJAAPZIFCQQQKX-NDEPHWFRSA-NSMILESCC1=C([C@@H](OC2=CC=C(O)C=C12)C1=CC=C(OCCN2CC(CF)C2)C=C1)C1=CC(O)=CC=C1

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of GDC-0927, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account